Lack of dominant-negative activity for tumor-associated ZNRF3 missense mutations at endogenous expression levels
S. Li, J. Niu, R. Zhang, S. Massaar, J. v. Merode, N. d. Schipper, L. v. d. Kamp, M. P. Peppelenbosch, R. Smits
This study shows that tumor-associated ZNRF3 missense mutations do not exhibit dominant-negative activity and instead act as loss-of-function mutations at endogenous levels.
bioRxiv · Mar 14, 2024Cancer Biology